Benutzerspezifische Werkzeuge

Publikationen 2011 - 2015

2015

Aust DE, Bläker H (2015). Histological diagnosis and complications of celiac disease. Update according to the new S2k guidelines. Pathologe 36(2): 197-205


Borkowetz A, Platzek I, Toma M, Laniado M, Baretton G, Froehner M, Koch R, Wirth M, Zastrow S (2015). Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer. BJU Int [epub ahead of print]


Cojoc M, Mäbert K, Muders MH, Dubrovska A (2015). A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms. Semin Cancer Biol 31: 16-27


Daubner D, Spieth S, Pablik J, Zöphel K, Paulus T, Laniado M (2015). Hibernoma-two patients with a rare lipoid soft-tissue tumour. BMC Med Imaging 15: 4


Foersch S, Sperka T, Lindner C, Taut A, Rudolph K, Breier G, Boxberger F, Rau TT, Hartmann A, Stürzl M, Wittkopf N, Haep L, Wirtz S, Neurath MF, Waldner MJ (2015). VEGFR2 signaling prevents colorectal cancer cell senescence to promote tumorigenesis in mice with colitis. Gastroenterology 149(1): 177-189


Froehner M, Koch R, Novotny V, Heberling U, Propping S, Litz RJ, Hübler M, Baretton GB, Hakenberg OW, Wirth MP (2015). Lee mortality index as comorbidity measure in patients undergoing radical cystectomy. Springerplus 4: 55


Froehner M, Koch R, Heberling U, Novotny V, Oehlschlaeger S, Hübler M, Baretton GB, Hakenberg OW, Wirth MP (2015).Decreased overall and bladder cancer- specific mortality with adjuvant chemotherapy after radical cystectomy: multivariable competing risk analysis. Eur Urol [epub ahead of print]


Jackson S, Schaefer J, Meinhardt M, Reichmann H (2015). Mitochondrial abnormalities in the myofibrillar myopathies. Eur J Neurol [epub ahead of print]


Kahlert C, Lerbs T, Pecqueux M, Herpel E, Hoffmeister M, Jansen L, Brenner H, Chang-Claude J, Bläker H, Kloor M, Roth W, Pilarsky C, Rahbari NN, Schölch S, Bork U, Reissfelder C, Weitz J, Aust D, Koch M (2015). Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer. Int J Cancer 137(9): 2104-13


Kast K, Link T, Friedrich K, Petzold A, Niedostatek A, Schoffer O, Werner C, Klug SJ, Werner A, Gatzweiler A, Richter B, Baretton G, Wimberger P (2015). Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treat 150(3): 621-9


Keck B, Wach S, Taubert H, Zeiler S, Ott OJ, Kunath F, Hartmann A, Bertz S, Weiss C, Hönscheid P, Schellenburg S, Rödel C, Baretton GB, Sauer R, Fietkau R, Wullich B, Krause FS, Datta K, Muders MH (2015). Neuropilin-2 and its ligand VEGF-C predict treatment response after transurethral resection and radiochemotherapy in bladder cancer patients. Int J Cancer 136(2): 443-51

Kirchberg J, Aust D, Fritzmann J, Folprecht G, Weitz J (2015). Genetisch stratifizierte Darmkrebstherapie. Forum 30(2): 127-133


Langner C, Aust D, Ensari A, Villanacci V, Becheanu G, Miehlke S, Geboes K,Münch A; The Working Group of Digestive Diseases of the European Society of Pathology (ESP); The European Microscopic Colitis Group (EMCG) (2015). Histology of Microscopic Colitis - Review with Practical Approach for Pathologists. Histopathology 66(5): 613-26


Meinel J, Radad K, Rausch WD, Reichmann H, Gille G (2015). Cabergoline protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture. Folia Neuropathol 53(1): 29-40


Papathomas TG, Oudijk L, Persu A, Gill AJ, van Nederveen F, Tischler AS, Tissier F, Volante M, Matias-Guiu X, Smid M, Favier J, Rapizzi E, Libe R, Currás-Freixes M, Aydin S, Huynh T, Lichtenauer U, van Berkel A, Canu L, Domingues R, Clifton-Bligh RJ, Bialas M, Vikkula M, Baretton G, Papotti M, Nesi G, Badoual C, Pacak K, Eisenhofer G, Timmers HJ, Beuschlein F, Bertherat J, Mannelli M, Robledo M, Gimenez-Roqueplo AP, Dinjens WN, Korpershoek E, de Krijger RR (2015). SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T). Mod Pathol 28(6): 807-21


Platzek I, Borkowetz A, Toma M, Brauer T, Meissner C, Dietel K, Wirth M, Laniado M (2015). Multiparametric prostate magnetic resonance imaging at 3 T: failure of magnetic resonance spectroscopy to provide added value. J Comput Assist Tomogr 39(5): 674-80


Probst A, Aust D, Märkl B, Anthuber M, Messmann H (2015). Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy 47(2): 113-21


Rad R, Rad L, Wang W, Strong A, Ponstingl H, Bronner IF, Mayho M, Steiger K, Weber J, Hieber M, Veltkamp C, Eser S, Geumann U, Ollinger R, Zukowska M, Barenboim M, Maresch R, Cadiñanos J, Friedrich M, Varela I, Constantino-Casas F,
Sarver A, Ten Hoeve J, Prosser H, Seidler B, Bauer J, Heikenwälder M, Metzakopian E, Krug A, Ehmer U, Schneider G, Knösel T, Rümmele P, Aust D, Grützmann R, Pilarsky C, Ning Z, Wessels L, Schmid RM, Quail MA, Vassiliou G, Esposito I, Liu P, Saur D, Bradley A (2015). A conditional piggyBac transposition system for genetic screening in mice identifies oncogenic networks in pancreatic cancer. Nat Genet 47(1): 47-56


Tannapfel A, Aust D, Baretton GB, Bläker H, Esposito I, Langner C, Vieth M, Wardelmann E, Kirchner T, Schirmacher P (2015). Remove polyps and discard. Way or wrong way? Pathologe 36(2): 182-5


Thiele S, Göbel A, Rachner TD, Fuessel S, Froehner M, Muders MH, Baretton GB, Bernhardt R, Jakob F, Glüer CC, Bornhäuser M, Rauner M, Hofbauer LC (2015). WNT5A has anti- prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo. J Bone Miner Res 30(3): 471-80

Toma M, Wehner R, Kloß A, Hübner L, Fodelianaki G, Erdmann K, Füssel S, Zastrow S, Meinhardt M, Seliger B, Brech D, Noessner E, Tonn T, Schäkel K, Bornhäuser M, Bachmann MP, Wirth MP, Baretton G, Schmitz M (2015). Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis. Oncoimmunology 4(6): e1008342


Waddell N, Pajic M, Patch AM, Chang DK, Kassahn KS, Bailey P, Johns AL, Miller D, Nones K, Quek K, Quinn MC, Robertson AJ, Fadlullah MZ, Bruxner TJ, Christ AN, Harliwong I, Idrisoglu S, Manning S, Nourse C, Nourbakhsh E, Wani S, Wilson PJ, Markham E, Cloonan N, Anderson MJ, Fink JL, Holmes O, Kazakoff SH, Leonard C, Newell F, Poudel B, Song S, Taylor D, Waddell N, Wood S, Xu Q, Wu J, Pinese M, Cowley MJ, Lee HC, Jones MD, Nagrial AM, Humphris J, Chantrill LA, Chin V, Steinmann AM, Mawson A, Humphrey ES, Colvin EK, Chou A, Scarlett CJ, Pinho AV, Giry-Laterriere M, Rooman I, Samra JS, Kench JG, Pettitt JA, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Jamieson NB, Graham JS, Niclou SP, Bjerkvig R, Grützmann R, Aust D, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Wolfgang CL, Morgan RA, Lawlor RT, Corbo V, Bassi C, Falconi M, Zamboni G, Tortora G, Tempero MA; Australian Pancreatic Cancer Genome Initiative, Gill AJ, Eshleman JR, Pilarsky C, Scarpa A, Musgrove EA, Pearson JV, Biankin AV, Grimmond SM (2015). Whole genomes redefine the mutational landscape of pancreatic cancer. Nature 518(7540): 495-501


Zeugner S, Mayr T, Zietz C, Aust DE, Baretton GB (2015). RNA quality in fresh-frozen gastrointestinal tumor specimens: experiences from the Tumor and Healthy Tissue Bank TU Dresden. Recent Results Cancer Res 199: 85-93


Zienert E, Eke I, Aust D, Cordes N (2015). LIM-only protein FHL2 critically determines survival and radioresistance of pancreatic cancer cells. Cancer Lett. 364(1): 17-24

2014

    1. Al-Janabi O, Taubert H, Lohse-Fischer A, Fröhner M, Wach S, Stöhr R, Keck C, Burger M, Wieland W, Erdmann K, Wirth MP, Wullich B, Baretton G, Magdolen V, Kotzsch M, Füssel S (2014). Association of Tissue mRNA and serum antigen levels of members of the Urokinase-Type Plasminogen Activator System with clinical and prognostic parameters in prostate cancer. Biomed Res Int 2014: 972587
    2. Bonnetain F, Bonsing B, Conroy T, Dousseau A, Glimelius B, Haustermans K, Lacaine F, Van Laethem JL, Aparicio T, Aust D, Bassi C, Berger V, Chamorey E, Chibaudel B, Dahan L, De Gramont A, Delpero JR, Dervenis C, Ducreux M, Gal J, Gerber E, Ghaneh P, Hammel P, Hendlisz A, Jooste V, Labianca R, Latouche A, Lutz M, Macarulla T, Malka D, Mauer M, Mitry E, Neoptolemos J, Pessaux P, Sauvanet A, Tabernero J, Taieb J, van Tienhoven G, Gourgou-Bourgade S, Bellera C, Mathoulin-Pélissier S, Collette L (2014) Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials). Eur J Cancer 50(17): 2983-2993
    3. Breier G, Grosser M, Rezaei M (2014). Endothelial cadherins in cancer. Cell Tissue Res 355(3): 523-527
    4. Casadonte R, Kriegsmann M, Zweynert F, Friedrich K, Baretton G, Otto M, Deininger S-O, Paape R, Belau E, Suckau D, Aust D, Pilarsky C, Kriegsmann J (2014). Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin- fixed paraffin- embedded tissues. Proteomics 14(7-8): 956-64
    5. Chamas A, Giersberg M, Friedrich K, Sonntag F, Kunze D, Uhlig S, Simon K, Baronian K, Kunze G (2014). Purification and immunodetection of the complete recombinant HER-2[neu] receptor produced in yeast. Protein Expr Purif 105C: 61-70
    6. Chatzigeorgiou A, Chung KJ, Garcia-Martin R, Alexaki VI, Klotzsche-von Ameln A, Phieler J, Sprott D, Kanczkowski W, Tzanavari T, Bdeir M, Bergmann S, Cartellieri M, Bachmann M, Nikolakopoulou P, Androutsellis-Theotokis A, Siegert G, Bornstein SR, Muders MH, Boon L, Karalis KP, Lutgens E, Chavakis T (2014). Dual role of B7 costimulation in obesity-related non-alcoholic steatohepatitis (NASH) and metabolic dysregulation. Hepatology 60(4): 1196-210
    7. Dalquen P, Savic Prince S, Spieler P, Kunze D, Neumann H, Eppenberger- Castori S, Adams H, Glatz K, Bubendorf L (2014). Making Cytological Diagnoses on Digital Images Using the iPath Network. Acta Cytol 58(5): 453-60
    8. Dietel M, Baretton G, Gabbert HE, Jung A, Kloor M, Liffers ST, Kreipe H, Schäfer KL, Schirmacher P, Sers C, Schlake W, Kirchner T (2014). Erweiterter RAS- Mutationsstatus. Onkologe 20: 492-496
    9. Al-Janabi O, Taubert H, Lohse-Fischer A, Fröhner M, Wach S, Stöhr R, Keck C, Burger M, Wieland W, Erdmann K, Wirth MP, Wullich B, Baretton G, Magdolen V, Kotzsch M, Füssel S (2014). Association of Tissue mRNA and serum antigen levels of members of the Urokinase-Type Plasminogen Activator System with clinical and prognostic parameters in prostate cancer. Biomed Res Int 2014: 972587
    10. Bonnetain F, Bonsing B, Conroy T, Dousseau A, Glimelius B, Haustermans K, Lacaine F, Van Laethem JL, Aparicio T, Aust D, Bassi C, Berger V, Chamorey E, Chibaudel B, Dahan L, De Gramont A, Delpero JR, Dervenis C, Ducreux M, Gal J, Gerber E, Ghaneh P, Hammel P, Hendlisz A, Jooste V, Labianca R, Latouche A, Lutz M, Macarulla T, Malka D, Mauer M, Mitry E, Neoptolemos J, Pessaux P, Sauvanet A, Tabernero J, Taieb J, van Tienhoven G, Gourgou-Bourgade S, Bellera C, Mathoulin-Pélissier S, Collette L (2014). Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials). Eur J Cancer 50(17): 2983-2993
    11. Breier G, Grosser M, Rezaei M (2014). Endothelial cadherins in cancer. Cell Tissue Res 355(3): 523-527
    12. Casadonte R, Kriegsmann M, Zweynert F, Friedrich K, Baretton G, Otto M, Deininger S-O, Paape R, Belau E, Suckau D, Aust D, Pilarsky C, Kriegsmann J (2014). Imaging mass spectrometry to discriminate breast from pancreatic cancer metastasis in formalin- fixed paraffin- embedded tissues. Proteomics 14(7-8): 956-64
    13. Chamas A, Giersberg M, Friedrich K, Sonntag F, Kunze D, Uhlig S, Simon K, Baronian K, Kunze G (2014). Purification and immunodetection of the complete recombinant HER-2[neu] receptor produced in yeast. Protein Expr Purif 105C: 61-70
    14. Chatzigeorgiou A, Chung KJ, Garcia-Martin R, Alexaki VI, Klotzsche-von Ameln A, Phieler J, Sprott D, Kanczkowski W, Tzanavari T, Bdeir M, Bergmann S, Cartellieri M, Bachmann M, Nikolakopoulou P, Androutsellis-Theotokis A, Siegert G, Bornstein SR, Muders MH, Boon L, Karalis KP, Lutgens E, Chavakis T (2014). Dual role of B7 costimulation in obesity-related non-alcoholic steatohepatitis (NASH) and metabolic dysregulation. Hepatology 60(4): 1196-210
    15. Dalquen P, Savic Prince S, Spieler P, Kunze D, Neumann H, Eppenberger- Castori S, Adams H, Glatz K, Bubendorf L (2014). Making Cytological Diagnoses on Digital Images Using the iPath Network. Acta Cytol 58(5): 453-60
    16. Dietel M, Baretton G, Gabbert HE, Jung A, Kloor M, Liffers ST, Kreipe H, Schäfer KL, Schirmacher P, Sers C, Schlake W, Kirchner T (2014). Erweiterter RAS- Mutationsstatus. Onkologe 20: 492-496
    17. Distler M, Aust D, Weitz J, Pilarsky C, Grützmann R (2014). Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN. Biomed Res Int 2014: 474905
    18. Distler M, Welsch T, Aust D, Weitz J, Grützmann R (2014). Intraduktale papillär- muzinöse Neoplasien (IPMN) des Pankreas – Standards und neue Aspekte. Zentralbl Chir 139: 308-317
    19. Dorn J, Gkazepis A, Kotzsch M, Kremer M, Propping C, Mayer K, Mengele K, Diamandis EP, Kiechle M, Magdolen V, Schmitt M (2014). Clinical value of protein expression of kallikrein-related peptidase 7 (KLK7) in ovarian cancer. Biol Chem 395(1): 95-107
    20. Erdmann K, Kaulke K, Thomae C, Huebner D, Sergon M, Froehner M, Wirth MP, Fuessel S. (2014). Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs. BMC Cancer 14: 82
    21. Evers L, Perez-Mancera PA, Lenkiewicz E, Tang N, Aust D, Knösel T, Rümmele P, Holley T, Kassner M, Aziz M, Ramanathan RK, Von Hoff DD, Yin H, Pilarsky C, Barrett MT (2014). STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma. Genome Med 6(1): 9
    22. Felber J, Aust D, Baas S, Bischoff S, Bläker H, Daum S, Keller R, Koletzko S, Laass M, Nothacker M, Roeb E, Schuppan D, Stallmach A (2014). Results of a S2k-Consensus Conference of the German Society of Gastroenterolgy, Digestive- and Metabolic Diseases (DGVS) in Conjunction with the German Coeliac Society (DZG) Regarding Coeliac Disease, Wheat Allergy and Wheat Sensitivity. Z Gastroenterol 52(7): 711-743
    23. Froehner M, Kellner AE, Koch R, Baretton GB, Hakenberg OW, Wirth MP (2014) A combined index to classify prognostic comorbidity in candidates for radical prostatectomy.BMC Urol 14: 28
    24. Froehner M, Koch R, Lossnitzer A, Schober RR, Schuler M, Wirth MP (2014). Adult inguinoscrotal sarcomas: outcome analysis of 21 cases, systematic review of the literature and meta-analysis. World J Urol 32(2): 445-51
    25. Fuessel S, Erdmann K, Taubert H, Lohse- Fischer A, Zastrow S, Meinhardt M, Bluemke K, Hofbauer L, Fornara P, Wullich B, Baretton G, Magdolen V, Wirth MP, Kotzsch M (2014). Prognostic impact of urokinas- type plasminogen activator system components in clear cell renal cell carcinoma patients without distant metastasis. BMC Cancer 14: 974
    26. Galli R, Uckermann O, Andresen EF, Geiger KD, Koch E, Schackert G, Steiner G, Kirsch M (2014). Intrinsic indicator of photodamage during label-free multiphoton microscopy of cells and tissues. PLoS one 9:e110295
    27. Gaumann AK, Drexler HC, Lang SA, Stoeltzing O, Diermeier-Daucher S, Buchdunger E, Wood J, Bold G, Breier G (2014). The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatanalib®). Int J Oncol 45(6): 2267-2277
    28. Haase MG, Geyer P, Fitze G, Baretton GB (2014). Down-regulation of heat shock protein HSP90ab1 in radiation-damaged lung cells other than mast cells. J Histochem Cytochem 62(5): 355-368
    29. Haustein M, Terai N, Pablik J, Pillunat LE, Sommer F (2014). Therapieresistente Oberlidschwellung im Kindesalter. Ophthalmologe 111(1): 53-7
    30. Hönscheid P, Datta K, Muders MH (2014). Autophagy: Detection, regulation and its role in cancer and therapy response. Int J Radiat Biol 90(8): 628-635
    31. Jahn S, Welsch T, Schaab F, Paulus T, Baretton G (2014). IgG4- assoziierte sklerosierende Cholangitis als Differentialdiagnose des hilären Gallengangskarzinoms. Gastroenterol up2date 10(3): 146
    32. Krautz C, Kuithan F, Dobroschke J, Nagel I, Hartmann S, Aust DE, Baretton G, Weitz J, Reissfelder C (2014). Peritoneal dissemination of a gastric API2-MALT1-positive MALT lymphoma. J Clin Pathol 67(8): 746-748
    33. Lacombe D, Tejpar S, Salgado R, Cardoso F, Golfinopoulos V, Aust D, Folprecht G, Roth A, Stupp R (2014). European perspective for effective cancer drug development. Nat Rev Clin Oncol 11(8): 492-498
    34. Laforest A, Aparicio T, Zaanan A, Silva FP, Didelot A, Desbeaux A, Le Corre D, Benhaim L, Pallier K, Aust D, Pistorius S, Blons H, Svrcek M, Laurent-Puig P (2014). ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma. Eur J Cancer 50(1): 1740-1746
    35. Linge A, Maurya P, Friedrich K, Baretton GB, Kelly S, Henry M, Clynes M, Larkin A, Meleady P (2014). Identification and functional validation of RAD23B as a potential protein in human breast cancer progression. J Proteome Res 13(7): 3212-3222
    36. Lohaus F, Linge A, Tinhofer I, Budach V, Gkika E, Stuschke M, Balermpas P, Rödel C, Avlar M, Grosu AL, Abdollahi A, Debus J, Bayer C, Belka C, Pigorsch S, Combs SE, Mönnich D, Zips D, von Neubeck C, Baretton GB, Löck S, Thames HD, Krause M, Baumann M; DKTK-ROG (2014). HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiother Oncol 113(3): 317-323
    37. Mamlouk S, Kalucka J, Singh RP, Franke K, Muschter A, Langer A, Jakob C, Gassmann M, Baretton GB, Wielockx B (2014). Loss of Prolyl Hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development. Int J Cancer 134(4): 849-858
    38. Mirza MK, Sukhanova M, Stölzel F, Onel K, Larson RA, Stock W, Ehninger G, Kuithan F, Zöphel K, Reddy P, Joseph L, Raca G (2014). Genomic aberrations in myeloid sarcoma without blood or bone marrow involvement: Characterization of formalin-fixed paraffin-embedded samples by chromosomal microarrays. Leuk Res 38(9): 1091-6
    39. Mostafa GM, Dalquen P, Kunze D, Terracciano L (2014). Telecytological diagnosis of space- occupying lesions of the liver. Acta Cytol 58(2): 174-81
    40. Okuda KV, Fitze G, Pablik J, Hahn G, Suttorp M, Vogelberg C (2014). Infantile myofibromatosis as an unusual cause for unilateral atelectasis in an infant. Pediatr Blood Cancer 61(7): 1158-9
    41. Ostheimer C, Bache M, Güttler A, Kotzsch M, Vordermark D (2014). A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor. Strahlenther Onkol 190(3): 276-82
    42. Putz J, Wirth MP, Froehner M, Jahn S (2014). Re: Zhu et al.: The expression and evaluation of androgen receptor in human renal cell carcinoma. Urology 84(3): 734-5
    43. Rachner TD, Göbel A, Thiele S, Rauner M, Benad- Mehner P, Hadji P, Bauer T, Muders MH, Baretton GB, Jakob F, Ebert R, Bornhäuser M, Schem C, Hofbauer LC (2014). Dickkopf-1 is regulated by the mevalonate pathway in breast cancer. Breast Cancer Res 16(1): R20
    44. Rachner TD, Thiele S, Göbel A, Browne A, Fuessel S, Erdmann K, Wirth MP, Fröhner M, Todenhöfer T, Muders MH, Kieslinger M, Rauner M, Hofbauer LC (2014). High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patients. BMC Cancer 14: 649
    45. Röcken C, Höfler H, Hummel M, Meyermann R, Zietz C, Schirmacher P (2014). Participation in and support of clinical studies and other scientific investigations - Statement of the German Society for Pathology. Pathol Res Pract 210: 705-712
    46. Schmelz R, Bornhäuser M, Schetelig J, Kiani A, Platzbecker U, Schwanebeck U, Grählert X, Uharek L, Aust D, Baretton G, Schwerdtfeger R, Hampe J, Greinwald R, Mueller R, Ehninger G, Miehlke S (2014). Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation. BMC Gastroenterol 14: 197
    47. Sommer U, Dietel K, Aust D, Bork U, Stange A, Koch M, Welsch T, Folprecht G, Weitz J, Laniado M, Baretton G (2014). Mixed adenoneuroendokrines Karzinom (MANEC) des rektosigmoidalen Überganges. Gastroenterol up2date 10(4): 224
    48. Sommer U, Larsson B, Tuve S, Wehner R, Zimmermann N, Kramer M, Kloß A, Günther C, Babatz J, Schmelz R, Brückner S, Schetelig J, Bornhäuser M, Schäkel K, Bachmann MP, Aust D, Baretton G, Schmitz M (2014). Proinflammatory human-6-sulfo LacNAc-positive dendritic cells accumulate in intestinal acute graft-versus-host disease. Haematologica 99: e86-e89
    49. Surov A, Tcherkes A, Meier F (2014). Intramuscular plasmacytoma. Skeletal Radiol 43(11): 1561-5
    50. Toma MI, Erdmann K, Diezel M, Meinhardt M, Zastrow S, Fuessel S, Wirth MP, Baretton GB (2014). Lack of ephrin receptor A1 is a favorable independent prognostic factor in clear cell renal cell carcinoma. Plos One 9(7): e102262
    51. Tsourdi E, Heidrich FM, Winzer M, Röllig C, Kirsch C, Meinel J, Baretton GB, Bornstein SR, Hofbauer LC (2014). An exotic cause of exudative enteropathy. Am J Case Rep 22(15): 226-229
    52. Tuve S, Sommer U, Kostka H, Mohr B, Oelschlägel U, Middeke JM, Berning M, Fantana J, Erler A, Jakob C, Aringer M, Baretton G, Schmitz M, Bornhäuser M, Babatz J (2014). Deletion 13q14 in plasma cells of patient with Lupus Erythematosus and autoimmune hepatitis. J Bone Marrow Res 2(2): 1000147
    53. Voigt E, Sommer F, Geiger KD, Pillunat LE (2014). Sebaceous gland tumor with a rare gene mutation within a tumor syndrome : Muir-Torre syndrome. Ophthalmologe 111(4): 369-72
    54. von Laffert M, Warth A, Penzel R, Schirmacher P, Kerr KM, Elmberger G, Schildhaus HU, Büttner R, Lopez-Rios F, Reu S, Kirchner T, Pauwels P, Specht K, Drecoll E, Höfler H, Aust D, Baretton G, Bubendorf L, Stallmann S, Fisseler-Eckhoff A, Soltermann A, Tischler V, Moch H, Penault-Llorca F, Hager H, Schäper F, Lenze D, Hummel M, Dietel M (2014). Multi-centre immunohistochemical ALK-testing of non-small cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria. J Thorac Oncol 9(11): 1685-92
    55. Weber T, Meinhardt M, Zastrow S, Wienke A, Erdmann K, Hofmann J, Fuessel S, Wirth MP (2014). Stage-dependent prognostic impact of molecular signatures in clear cell renal cell carcinoma. Onco Targets Ther 7: 645-654
    56. Weissmueller S, Manchado E, Saborowski M, Morris JP 4th, Wagenblast E, Davis CA, Moon SH, Pfister NT, Tschaharganeh DF, Kitzing T, Aust D, Markert EK, Wu J, Grimmond SM, Pilarsky C, Prives C, Biankin AV, Lowe SW (2014). Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling. Cell 157(2): 382-94
    57. Zhou W, Jubb AM, Lyle K, Xiao Q, Ong CC, Desai R, Fu L, Gnad F, Song Q, Haverty PM, Aust D, Grützmann R, Romero M, Totpal K, Neve RM, Yan Y, Forrest WF, Wang Y, Raja R, Pilarsky C, de Jesus-Acosta A, Belvin M, Friedman LS, Merchant M, Jaffee EM, Zheng L, Koeppen H, Hoeflich KP (2014). PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition. J Pathol 234: 512-13

2013

    1. Aust DE (2013). Microscopic colitis – demands on histopathological diagnostics. Endoskopie heute 26(1): 62-65
    2. Aust DE, Baretton GB (2013). Barrett- Ösophagus: Indikatoren für die Karzinomentwicklung. Gastroenterologe 8(6): 487-494
    3. Baretton GB (2013). Report from the working group on gastroenteropathology. Pathologe 34(Suppl 2): 284-5
    4. Bergner N, Medyukhina A, Geiger KD , Kirsch M, Schackert G, Krafft C, Popp J. (2013). Hyperspectral unmixing of Raman micro-images for assessment of morphological and chemical parameters in non-dried brain tumor specimens Anal Bioanal Chem 405(27): 8719-28
    5. Corcoran A, Kunze R, Harney SC, Breier G , Marti HH, O'Connor JJ (2013). A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity. Hippocampus 23(10): 861-872
    6. Distler M, Kersting S, Niedergethmann M, Aust DE , Franz M, Rückert F, Ehehalt F, Pilarsky C, Post S, Saeger HD, Grützmann R (2013). Pathohistological Subtype Predicts Survival in Patients With Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Ann Surg 258(2): 324-30
    7. Dornbusch J, Zacharis A, Meinhardt M, Erdmann K, Wolff I, Froehner M, Wirth MP, Zastrow S, Fuessel S (2013). Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma PLoS One 8(9): e76386
    8. Franke K, Kalucka J, Mamlouk S, Singh RP, Muschter A , Weidemann A, Iyengar V, Jahn S, Wieczorek K, Geiger K, Muders M, Sykes AM, Poitz D, Ripich T, Otto T, Bergmann S, Breier G, Baretton G, Fong GH, Greaves DR, Bornstein S, Chavakis T, Fandrey J, Gassmann M, Wielockx B (2013). HIF-1 α is a protective factor in conditional PHD2 deficient mice suffering from severe HIF-2 α -induced excessive erythropoiesis. Blood 121(8): 1436-45
    9. Franke K , Gassmann M, Wielockx B . (2013). Erythrocytosis: the HIF pathway in control. Blood 122(7): 1122-1128
    10. Froehner M, Schober RR, Koch R, Lossnitzer A , Laniado M, Wirth MP (2013). Adult urologic sarcoma: experience during 2 decades. Urol Oncol . 2013; 31(7): 985-9
    11. Gilbert JA, Adhikari LJ, Lloyd RV, Halfdanarson TR, Muders MH , Ames MM (2013). Molecular Markers for Novel Therapeutic Strategies in Pancreatic Endocrine Tumors. Pancreas 42(3): 411-421
    12. Griesmann H, Ripka S, Pralle M, Ellenrieder V, Baumgart S, Buchholz M, Pilarsky C, Aust D , Gress TM, Michl P (2013). WNT5A-NFAT signaling mediates resistance to apoptosis in pancreatic cancer. Neoplasia 15(1): 11-22
    13. Haase MG, Liepe K, Faulhaber D, Wunderlich G, Andreeff M, Jung R, Baretton GB , Fitze G, Kotzerke J (2013). Dose-dependent histological alterations in the rat lung following intravenous application of Re-188-labeled microspheres. Int J Radiat Biol 89(10): 863-9 IF 1.895
    14. Hermann A, Loewenbrück KF, Boldt Ä, Fiedler C, Maisel M, Kalucka J, Schwarz J, Breier G, Storch A (2013). Lack of vascular endothelial growth factor receptor-2/Flk1 signaling does not affect substantia nigra development. Neurosci Lett 553: 142-147
    15. Hoffmann AC, Goekkurt E, Danenberg PV, Lehmann S, Ehninger G, Aust DE , Stoehlmacher-Williams J (2013). EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma. PLoS One 8(5): e64186
    16. Juratli TA, Peitzsch M, Geiger K , Schackert G, Eisenhofer G, Krex D (2013). Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas. Neuro Oncol 15(6): 682-90
    17. Juratli TA, Geiger K , Leimert M, Schackert G, Kirsch M (2013). Atypical Central Neurocytoma with Recurrent Spinal Dissemination over a Period of 20 Years: A Case Report and Review of the Literature. Case Rep Neurol Med 2013 : 925647
    18. Kalucka J, Ettinger A, Franke K, Mamlouk S, Singh RP , Farhat K, Muschter A , Olbrich S, Breier G , Katschinski DM, Huttner W, Weidemann A, Wielockx B (2013). Loss of Epithelial HIF Prolyl Hydroxylase-2 (PHD2) Accelerates Skin Wound Healing in Mice. Mol Cell Biol 33(17): 3426-3438
    19. Klotzsche-von Ameln A , Prade I , Grosser M , Kettelhake A , Rezaei M , Chavakis T , Flamme I , Wielockx B , Breier G (2013). PHD4 Stimulates Tumor Angiogenesis in Osteosarcoma Cells via TGF-α. Mol Cancer Res 11(11): 1337-48
    20. Lehner A, Magdolen V, Schuster T, Kotzsch M, Kiechle M, Meindl, A, Sweep FCGJ, Span Paul N, Gross, E (2013). Downregulation of Serine Protease HTRA1 is associated with poor survival in Breast cancer. Plos One 8(4): e60359
    21. Leimert M , Juratli TA , Lindner C , Geiger KD , Gerber J , Schackert G , Kirsch M (2013). An extremely rare, remote intracerebral metastasis of oral cavity cancer: a case report . Case Rep Med 2013 : 257046
    22. Mamlouk S, Wielockx B (2013). Hypoxia- inducible factors as key regulators of tumor inflammation Int J Cancer 132(12): 2721-2729
    23. Meinel J, Herzog K, Baretton GB (2013). Von der Biopsie bis zum histologischen Befund. Endo-Praxis 29(4): 166-170
    24. Miehlke S, Aust D , Madisch A (2013). Mikroskopische Kolitis – neue praxisrelevante Erkenntnisse. Z Gastroenterol . 51(12): 1389-1394
    25. Miehlke S, Hansen JB, Madisch A, Schwarz F, Kuhlisch E, Morgner A, Teglbjaerg PS, Vieth M, Aust D , Bonderup OK (2013). Risk Factors for Symptom Relapse in Collagenous Colitis After Withdrawal of Short-term Budesonide Therapy. Inflamm Bowel Dis . 2013; 19(13): 2763-2767
    26. Nakayama M, Nakayama A, Van Lessen M, Yamamoto H, Hoffmann S, Drexler HCA, Itoh N, Hirose T, Breier G, Vestweber D, Cooper JA, Ohno S, Kaibuchi K, Adams RH (2013). Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol 15(3): 249-260
    27. Ordemann R , Stöhlmacher J , Beuthien-Baumann B , Platzek I , van den Hoff J , Kroschinsky F , Middeke JM , Platzbecker U , Zietz C , Bornhäuser M , Ehninger G (2013). Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation . Ann Hematol 92(1): 125-127
    28. Pfluecke C, Ulbrich S, Ibrahim K, Geiger KD , Strasser RH, Wunderlich C (2013). Chronic diarrhea as the initial clinical manifestation of light-chain amyloidosis with cardiac involvement despite negative duodenal and rectal biopsies. Exp Clin Cardiol 18(2): 148-50
    29. Röcken C, Höfler H, Hummel M, Meyermann R, Zietz C , Schirmacher P (2013). Participation and support of clinical studies and other scientific investigations: Statement of the German Society for Pathology. Pathologe 34(5): 466-475
    30. Singh RP, Franke K, Kalucka J, Mamlouk S, Muschter A, Gembarska A, Grinenko T, Willam C, Naumann R, Anastassiadis K, Stewart AF, Bornstein S, Chavakis T, Breier G, Waskow C , Wielockx B (2013). HIF prolyl hydroxylase 2 (PHD2) is a critical regulator of hematopoietic stem cell maintenance during steady-state and stress. Blood 121(26): 5158-66
    31. Stanton MJ , Dutta S , Zhang H , Polavaram NS , Leontovich AA , Hönscheid P , Sinicrope FA , Tindall DJ , Datta K* , Muders MH* (2013). Autophagy control by VEGF-C/NRP-2 axis in cancer and its implication for treatment resistance. Cancer Res 73(1): 160-171; *contributed equally
    32. Stanton MJ, Dutta S, Polavaram NS, Roy S, Muders MH , Datta K (2012). Angiogenic growth factor axis in autophagy regulation. Autophagy 9(5): 789-790
    33. Stelling AL, Toher D, Uckermann O, Tavkin J, Leipnitz E, Schweizer J, Cramm H, Steiner G, Geiger KD , Kirsch M (2013). Infrared spectroscopic studies of cells and tissues: triple helix proteins as a potential biomarker for tumors. PLoS One 8(3): e58332
    34. Sturm D, Marselli L, Ehehalt F, Richter D, Distler M, Kersting S, Grützmann R, Bokvist K, Froguel P, Liechti R, Jörns A, Meda P, Baretton GB , Saeger HD, Schulte AM, Marchetti P, Solimena M (2013). Improved protocol for laser microdissection of human pancreatic islets from surgical specimens. J Vis Exp (JoVE) 6(71)
    35. Taubert H, Magdolen V, Kotzsch M (2013). Impact of expression of the uPA system in sarcomas. Biomark Med 7(3): 473-80
    36. Thieme S, Gyárfás T, Richter C, Ozhan G, Fu J, Alexopoulou D, Muders MH , Michalk I, Jakob C , Dahl A, Klink B, Bandola J, Bachmann M, Schröck E, Buchholz F, Stewart AF, Weidinger G, Anastassiadis K, Brenner S (2013). The histone demethylase UTX regulates stem cell migration and hematopoiesis. Blood 121(13): 2462-73
    37. Toma MI , Wuttig D, Kaiser S, Herr A, Weber T, Zastrow S, Koch R , Meinhardt M, Baretton G , Wirth MP, Fuessel S (2013). PARK2 and PARKG are commonly down- regulated in clear- cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome. Genes Chromosomes Cancer 52(3): 265-273
    38. Vlenterie M, Flucke U, Hofbauer LC, Timmers HJ, Gastmeier J, Aust DE , van der Graaf WT, Wesseling P, Eisenhofer G, Lenders JW (2013). Pheochromocytoma and gastrointestinal stromal tumors in patients with neurofibromatosis type I. Am J Med 126(2): 174-80
    39. Wang L, Benedito R, Bixel MG, Zeuschner D, Stehling M, Sävendahl L, Haigh JJ, Snippert H, Clevers H, Breier G, Kiefer F, Adams RH (2013). Identification of a clonally expanding haematopoietic compartment in bone marrow. EMBO J 32 (2): 219-230
    40. Weber T , Meinhardt M , Zastrow S, Wienke A, Fuessel S, Wirth MP (2013). Immunohistochemical analysis of prognostic protein markers for primary localized clear cell renal cell carcinoma. Canc er Invest 31(1): 51-9

2012

  1. Aust DE , Sommer U , Baretton GB (2012). What can molecular pathology offer for optimal decision making? Ann Oncol 23 (Suppl 10): x63-x70
  2. Aust DE (2012). Histopathologie der mikroskopischen Kolitis. [Histopathology of microscopic colitis]. Pathologe 33(Suppl. 2):221-224
  3. Baretton GB, Aust DE (2012). Barrett's esophagus: An update Pathologe 33(1):5-16
  4. Bergner N, Krafft C, Geiger KD , Kirsch M, Schackert G, Popp J (2012). Unsupervised unmixing of Raman microspectroscopic images for morphochemical analysis of non-dried brain tumor specimens. Anal Bioanal Chem 403(3):719-725
  5. Breier G (2012). Propanolol and angiogenesis inhibition in hereditary haemorrhagic telangiectasia. Thromb Haemostasis 108(1):1-2
  6. Därr R, Zöphel K, Eisenhofer G, Abolmaali N, Gastmeier J, Wieczorek K , Jelinek, V, Kamvissi V, Bornstein SR, Hofbauer LC (2012). Combined use of 68Ga-DOTATE and 18F-FDG PET/CT to localize a bronchial carcinoid associated with ectopic ACTH syndrome J Clin Endocrinol Metab 97(7):2207-2208
  7. Daubner D, Friedrich K , Spieth s (2013). Lactating adenoma of the breast – differential diagnosis in pregnancy and during breast feeding. Rofo 184(10):934-935
  8. de Albuquerque A, Kubisch I, Ernst D, Breier G , Stamminger G, Fersis N, Stölzel U, Boese- Landgraf J, Eichler A, Kaul S (2013). Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients Clin Lab 58(5-6):373-384
  9. de Albuquerque A, Kubisch I, Breier G , Stamminger G, Fersis N, Eichler A, Kaul S, Stölzel U (2013). Multimarker Gene Analysis of Circulating Tumor Cells in Pancreatic. Cancer Patients: A Feasibility Study. Oncology 82(1):3-10
  10. de Albuquerque A, Kaul S, Breier G , Krabisch P, Fersis N (2012). Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine. Breast Care (Basel) 7(1):7-12
  11. de Albuquerque A, Kubisch I, Stölzel U, Ernst D, Boese-Landgraf J, Breier G , Stamminger G, Fersis N, Kaul S (2012). Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients. J Transl Med 13(10):222
  12. Eberlein- Gonska M, Baretton G , Habeck JO (2012). Peer review Verfahren in der Pathologie – mehr als zehn Jahre Erfahrungen im Freistaat Sachsen [Peer review procedures in pathology – more than ten years of experience in the Free State of Saxony]. Z Evid Fortbild Qual Gesundhwes 106(8):571-578
  13. Friedrichs, N, Kahl P, Aust D , Steinke Y, Baretton G , Büttner R (2012). Diagnostik hereditärer Tumorerkrankungen: Rolle der Pathologie als Bestandteil des Deutschen Konsortiums für erblichen Darmkrebs (HNPCC). Fokus 27(1):42-46
  14. Froehner M, Scholz A, Koch R, Hakenberg OW, Baretton GB , Wirth MP (2012). Competing Mortality Contributes to Excess Mortality in Patients with Poor-Risk Lymph Node-Positive Prostate Cancer Treated with Radical Prostatectomy. Urol Int 89(2):148-54
  15. Grismayer B, Sato S, Kopitz C, Ries C, Soelch S, Schmitt M, Baretton G , Krüger A, Luther T, Kotzsch M, Magdolen V (2012). Overexpression of the urokinase receptor splice variant uPAR-del4/5 in breast cancer cells affects cell adhesion and invasion in a dose-dependent manner and modulates transcription of tumor-associated genes Biol Chem 393(12):1449-1455
  16. Grismayer B, Sölch S, Seubert B, Kirchner T, Schäfer S, Baretton G , Schmitt M, Luther T, Krüger A, Kotzsch M, Magdolen V (2012). Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells. Mol Cancer 11:62
  17. Hahnel A, Wichmann H, Greither T, Kappler M, Wurl P, Kotzsch M , Taubert H, Vordermark D, Bache M (2012). Prognostic impact of mRNA levels of osteopontin splicevariants in soft tissue sarcoma patients. BMC Cancer 12(1):131
  18. Hamann C, Lützner J, Wieczorek K , Hofbauer LC (2012). Pulmonary metastases due to a giant- Cell tumor of bone. J Clin Endocr Metab 97(10):3408-3409
  19. Juratli TA, Kirsch M, Robel K, Soucek S, Geiger K , von Kummer R, Schackert G, Krex D (2012). IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas. J Neurooncol 108(3):403-410
  20. Kast K, Krause M, Schuler M, Friedrich K , Thamm B, Bier A, Distler W, Krüger S (2012). Late onset Li-Fraumeni syndrome with bilateral breast cancer and other malignancies: case report and review of the literature. BMC Cancer 12(1):217
  21. Klotzsche-von Ameln A , Muschter A , Heimesaat MM, Breier G, Wielockx B (2012). HIF prolyl hydroxylase-2 inhibition diminishes tumor growth through matrix metalloproteinase-induced TGF β activation. Cancer Biol Ther 13(4):216-23
  22. Kunze R , Zhou W , Veltkamp R , Wielockx B , Breier G , Marti HH (2012). Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia. Stroke 43(10):2748-56
  23. Kuzmanov A, Wielockx B, Rezaei M, Kettelhake A, Breier G (2012). Overexpression of factor inhibiting HIF-1 enhances vessel maturation and tumor growth via platelet-derived growth factor-C. Int J Cancer 131(5):E603-E613
  24. Linke J , Neudert M , Forberger A , Zahnert T (2012) Exophytischer gestielter Halstumor. HNO 60(10):908-912
  25. Lutz MP , Zalcberg JR , Ducreux M , Ajani JA , Allum W , Aust D , Bang YJ , Cascinu S , Hölscher A , Jankowski J , Jansen EP , Kisslich R , Lordick F , Mariette C , Moehler M , Oyama T , Roth A , Rueschoff J , Ruhstaller T , Seruca R , Stahl M , Sterzing F , van Cutsem E , van der Gaast A , van Lanschot J , Ychou M , Otto F (2012). Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - Differential treatment strategies for subtypes of early gastroesophageal cancer. Eur J Cance r 48(16):2941-53
  26. Mente C, Prade I, Brusch L, Breier G , Deutsch A (2012). A lattice- gas cellular automaton model for in vitro sprouting angiogenesis. Acta Physica Polonica. B (Proceedings Suppl) 5(1):99-115
  27. Münch A, Aust D , Bohr J, Bonderup O, Fernández Bañares F, Hjortswang H, Madisch A, Munck LK, Ström M, Tysk C, Miehlke S; European Microscopic Colitis Group (EMCG) (2012). Microscopic colitis: current status, present and future challenges. Statements of the European Microscopic Colitis Group. J Crohns Colitis 6(9):932-45
  28. Parmentier S, Meinel J, Oelschlaegel U, Mohr B, Ehninger G, Schaich M, Platzbecker U (2012). Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome. Ann Hematol 91(12):1979-1981
  29. Pérez-Mancera PA, Rust AG, van der Weyden L, Kristiansen G, Li A, Sarver AL, Silverstein KA, Grützmann R, Aust D , Rümmele P, Knösel T, Herd C, Stemple DL, Kettleborough R, Brosnan JA, Li A, Morgan R, Knight S, Yu J, Stegeman S, Collier LS, ten Hoeve JJ, de Ridder J, Klein AP, Goggins M, Hruban RH, Chang DK, Biankin AV, Grimmond SM; Australian Pancreatic Cancer Genome Initiative, Wessels LF, Wood SA, Iacobuzio-Donahue CA, Pilarsky C, Largaespada DA, Adams DJ, Tuveson DA (2012). The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature 486(7402):266-270
  30. Planas-Paz L, Strilić B, Goedecke A, Breier G , Fässler R, Lammert E (2012). Mechanoinduction of lymph vessel expansion EMBO J  31(4):788-804
  31. Rezaei M, Friedrich K, Wielockx B , Kuzmanov A, Kettelhake A, Labelle M , Schnittler H, Baretton G, Breier G (2013). Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression. Breast Cancer Res 14(6):R154
  32. Rückert F, Aust D , Böhme I, Werner K, Brandt A, Diamandis EP, Krautz C, Hering S, Saeger HD, Grützmann R, Pilarsky C (2012). Five Primary Human Pancreatic Adenocarcinoma Cell Lines Established by the Outgrowth Method. J Surg Res 172(1):29-39
  33. Seiz L, Dorn J, Kotzsch M , Walch A, Grebenchtchikov NI, Gkazepis A, Schmalfeldt B, Kiechle M, Bayani J, Diamandis EP, Langer R, Sweep FC, Schmitt M, Magdolen V (2012). Stromal cell-associated expression of kallikrein-related peptidase 6 (KLK6) indicates poor prognosis of ovarian cancer patients. Biol Chem 393(5):391-401
  34. Singer A , Deuse Y , Koch U , Hölscher T , Pfitzmann D , Jakob C , Hehlgans S , Baretton GB , Rentsch A , Baumann M , , Krause M*, Muders MH* (2012). Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer. Strahlenther Onkol 188(12):1125-1132; *contributed equally
  35. Singh RP, Franke K, Wielockx B (2012). Hypoxia- mediated regulation of stem cell fate. High Altitude medicine & biology 13(3):162-168
  36. Steiner G, Mackenroth L, Geiger KD , Stelling A, Pinzer T, Uckermann O, Sablinskas V, Schackert G, Koch E, Kirsch M (2012). Label- free differentiation of human pituary adenomas by FT-IR spectroscopic imaging. Anal Bioanal Chem 403(3):727-735
  37. Stölzel F, Hackmann K, Kuithan F , Mohr B, Füssel M, Oelschlägel U, Thiede C, Röllig C, Platzbecker U, Schetelig J, Illmer T, Schaich M, Seliger B, Hartmann A, Baretton G, Zietz C , Ehninger G, Schrock E, Bornhäuser M (2012). Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation 93(7):744-749
  38. Trautmann K , Jakob C , von Grünhagen U , Schleyer E , Brümmendorf TH , Siegert G , Ehninger G , Platzbecker U (2012). Eltrombopag fails to improve severe thrombocytopenia in late-stage dyskeratosis congenita and diamond-blackfan-anaemia. Thromb Haemost 108(2):397-8
  39. Van Laethem JL, Verslype C, Iovanna JL, Michl P, Conroy T, Louvet C, Hammel P, Mitry E, Ducreux M, Maraculla T, Uhl W, Van Tienhoven G, Bachet JB, Maréchal R, Hendlisz A, Bali M, Demetter P, Ulrich F, Aust D , Luttges J, Peeters M, Mauer M, Roth A, Neoptolemos JP, Lutz M (2012). New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel. Ann Oncol 23(3):570-6
  40. Winter C, Kristiansen G, Kersting S, Roy J, Aust D , Knösel T, Rümmele P, Jahnke B, Hentrich V, Rückert F, Niedergethmann M, Weichert W, Bahra M, Schlitt HJ, Settmacher U, Friess H, Büchler M, Saeger HD, Schroeder M, Pilarsky C, Grützmann R (2012). Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes. PLoS Comput Biol 8(5):e1002511
  41. Wuttig D, Zastrow S, Füssel S, Toma MI, Meinhardt M , Kalman K, Junker K,
  42. Sanjmyatav J, Boll K, Hackermüller J, Rolle A, Grimm MO, Wirth MP (2012) . CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases Int J Cancer 131(5):E693-E704

2011

  1. Aust DE (2011). WHO classification 2010 for the lower gastrointestinal tract: What is new? Pathologe 32(Suppl. 2):326-31
  2. Aust DE, Baretton GB (2011). Nonbacterial colitides. Pathologe 32(5):379-83
  3. Aust DE , Rüschoff J (2011). Polyps of the colorectum: Non-neoplastic and non-hamartomatous. Pathologe 32(4):297-302
  4. Baretton GB, Aust DE (2011). Bacterial colitis. Pathologe . 32(5):371-8
  5. Baretton GB, Aust DE (2011). Serrated precursor lesions. Pathologe . 2011 ; 32(Suppl. 2):211-7
  6. Baretton GB , Tannapfel A, Schmitt W (2011). Standardized and structured histopathological evaluation of colorectal polyps: A practical checklist against the background of the new WHO classification. Pathologe 32(4):289-296
  7. Baretton GB (2011). Report from the Gastroenteropathology plc. Pathologe 32(Suppl. 2):339-340
  8. Baretton G (2011). Pathology of the lower gastrointestinal tract. Pathologe 32(4):273-274
  9. Baretton GB, Aust DE ( 2011). Neues von der Adenom-Karzinom-Sequenz Endo Heute 24(3):164-170
  10. Baretton GB , Autschbach F, Baldus S, Bläker H, Faller G, Koch HK, Langner C, Lüttges J, Neid M, Schirmacher P, Tannapfel A, Vieth M, Aust DE (2011 ). Histopathological diagnosis and differential diagnosis of colorectal serrated polyps: Findings of a consensus conference of the working group "Gastroenterological pathology of the German Society of Pathology". Pathologe 32(1):76-82
  11. Baretton G , Grabbe S, Keilholz U, Sauter G (2011). Molekulare Diagnostik und Therapie in der Onkologie. Onkologie 34 (Suppl 2):5-9
  12. Baretton GB, Aust DE (2011). Serratierte Läsionen im Kolorektum – ein pathologisches Problem oder ein Problem der Pathologen? Vizeralmedizin 27:309-315
  13. Bauer W, Rauner M, Haase M , Kujawski S, Arabanian LS, Habermann I, Hofbauer L,Ehninger G, Kiani A (2011). Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2. Haematologica 96(11):1580-8
  14. Beleites C, Geiger K , Kirsch M, Sobottka SB, Schackert G, Salzer R (2011). Raman spectroscopic grading of astrocytoma tissues: using soft reference information. Anal Bioanal Chem 400(9):2801-16
  15. Bötticher G, Sturm D, Ehehalt F, Knoch KP, Kersting S, Grützmann R, Baretton GB , Solimena M, Saeger HD (2011). Isolation of Human Islets from Partially Pancreatectomized Patients. J Vis Exp (JoVe) 30(53):2962
  16. Boltze J., Nitzsche B., Geiger KD , Schoon HA (2011). Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model . Translat Stroke Res 2:279-293
  17. Brandt K, Meinel J , Laniado M, Schaich M (2011). Acute lymphoblastic leukaemia in apatient with osteopoikilosis. Br J Haematol 155(5):535
  18. Dignass A, Preiß JC, Aust DE , Autschbach F, Ballauff A, Baretton G , Bokemeyer B, Fichtner-Feigl S, Hagel S, Herrlinger KR, Jantschek G, Kroesen A, Kruis W, Kucharzik T, Langhorst J, Reinshagen M, Rogler G, Schleiermacher D, Schmidt C, Schreiber S, Schulze H, Stange E, Zeitz M, Hoffmann JC, Stallmach A (2011). Updated German Guideline on Diagnosis and Treatment of Ulcerative Colitis, 2011 Z Gastroenterol 49(9):1276-1341
  19. Distler M, Rückert F, Aust D , Saeger HD, Grützmann R (2011). Pancreatic Heterotopia of the Duodenum: Anatomic Anomaly or Clinical Challenge? J Gastrointest Surg 15(4):631-6
  20. Ehehalt F, Rümmele P, Kersting S, Lang-Schwarz C, Rückert F, Hartmann A, Dietmaier W, Terracciano L, Aust DE , Jahnke B, Saeger HD, Pilarsky C, Grützmann R (2011). Hepatocyte Nuclear Factor (HNF) 4 α Expression Distinguishes Ampullary Cancer Subtypes and Prognosis After Resection. Ann Surg 254(2):302-10
  21. Gaisa NT, Braunschweig T, Reimer N, Bornemann J, Eltze E, Siegert S, Toma M ,Villa L, Hartmann A, Knuechel R (2011). Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer. Virchows Arch 0351 458-(3):301-12
  22. Geiger KD , Hendruschk S, Rieber EP, Morgenroth A, Weigle B, Juratli T, Senner V, Schackert G, Temme A (2011). The prostate stem cell antigen represents a novel glioma-associated antigen. Oncol Rep 26(1):13-21
  23. Gerbes AL, Gülberg V, Sauerbruch T, Wiest R, Appenrodt B, Bahr MJ, Dollinger MM, Rössle M, Schepke M, Baretton G (2011). German S 3-Guideline "Ascites, spontaneous bacterial peritonitis, hepatorenal syndrome". Z Gastroenterol 49(6):749-779
  24. Grosser M , Magdolen V, Baretton G , Luther T, Albrecht S (2011). Gene expression analysis of HUVEC in response to TF-binding. Thromb Res 127(3):259-63
  25. Günther C, Zimmermann N, Berndt N, Grosser M , Stein A, Koch A, Meurer M (2011). Up-regulation of the Chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-Cell lymphoma. Am J Pathol 179(3):1434-1442
  26. Hauck F, Lee-Kirsch MA, Aust D , Roesler J, Pessler F (2011). Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: Treatment with rituximab. Arthritis Care Res (Hoboken) 63(3):454-459
  27. Hedrich CM, Zappel H, Straub S, Laass MW, Wieczorek K , Hahn G, Heubner G, Gahr M (2011). Early onset systemic lupus erythematosus: differential diagnoses, clinical presentation, and treatment options. Clin Rheumatol 30(2):275-83
  28. Hölscher M, Silter M, Krull S, von Ahlen M, Hesse A, Schwartz P, Wielockx B , Breier G , Katschinski DM, Zieseniss A (2011). Cardiomyocyte-specific Prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischaemic injury. J Biol Chem 286(13):11185-94
  29. Ibrahim K, Jellinghaus S, Christoph M, Pfluecke C, Guenther M, Ney M, Baretton G , Schoen S, Strasser RH (2011). Intracranial hemorrhage causes a transmural myocardial infarction without the presence of coronary atherosclerosis. Int J Cardiol 152(2):e40-1
  30. Jakob C, Aust DE , Liebscher B , Baretton GB , Datta K, Muders MH (2011). Lymphangiogenesis in regional lymph nodes is an independent prognostic marker in rectal cancer patients after neoadjuvant treatment. PLoS One 6(11):e27402
  31. Kern A, Görgens H, Dittert DD , Krüger S, Richter KK, Schackert HK, Saeger HD, Baretton G , Pistorius S (2011). Mutational status of KIT and PDGFRA and expression of PDGFRA are not associated with prognosis after curative resection of primary gastrointestinal stromal tumors (GISTs). J Surg Oncol 104(1):59-65
  32. Klotzsche-von Ameln A, Muschter A, Mamlouk S, Kalucka J, Prade I, Franke K, Rezaei M , Poitz DM, Breier G, Wielockx B (2011). Inhibition of HIF Prolyl Hydroxylase-2 blocks tumor growth in mice through the anti-proliferative activity of transforming growth factor{beta}. Cancer Res 71(9):3306-16
  33. Kotzsch M , Magdolen V, Greither T, Kappler M, Bache M, Lautenschlager C, Fussel S, Eckert AW, Luther T, Baretton G, Wurl P, Taubert H (2011). Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patients. BMC Cancer 11(1):273-281
  34. Kotzsch M, Dorn J, Doetzer K, Schmalfeldt B, Krol J, Baretton G , Kiechle M, Schmitt M, Magdolen V (2011). mRNA expression levels of the biological factors uPAR, uPAR-del4/5 and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer. Biol Chem 392(11):1047-51
  35. Langer HF, Orlova VV, Xie C, Kaul SC, Schneider D, Lonsdorf A, Fahrleitner M, Choi EY, Dutoit V, Pellegrini M, Grossklaus S, Nawroth P, Baretton GB, Santoso S, Hwang ST, Arnold B, Chavakis T (2011). A novel function of Junctional Adhesion Molecule-C in mediating melanoma cell metastasis. Cancer Res 71(12):4096-105
  36. Liepe K, Faulhaber D, Wunderlich G, Andreeff M, Haase M, Jung R, Oehme L, Dörr W, Kotzerke J (2011). Radiation Pneumopathy in the rat after intravenous application of (188) re-labeled microspheres. Int J Radiat Oncol Biol Phys 81(2):529-36
  37. List C, Parmentier S, Jahn S , Schuler U, Kroschinsky F (2011). Bone marrow carcinosis as initial presentation of adeno carcinoma. Internist 52(3):324-327
  38. Mente C, Prade I , Brusch L, Breier G , Deutsch A (2011). Parameter estimation with a novel gradient-based optimization method for biological lattice-gas cellular automaton models. J Math Biol 63(1):173-200
  39. Miehlke S, Morgner A, Aust D, Baretton G , Madisch A (2011). Probe-based Confocal Laser Endomicroscopy in Double Balloon Enteroscopy. Z Gastroenterol 49(12):1529-1534
  40. Missol-Kolka E, Karbanová J, Janich P , Haase M , Fargeas CA, Huttner WB, Corbeil D (2011). Prominin-1 (CD133) is not restricted to stem cells located in the basal compartment of murine and human prostate. Prostate 71(3):254-67
  41. Moehler M1, Al-Batran SE, Andus T, Anthuber M, Arends J, Arnold D, Aust D , Baier P, Baretton G , Bernhardt J, Boeing H, Böhle E, Bokemeyer C, Bornschein J, Budach W, Burmester E, Caca K, Diemer WA, Dietrich CF, Ebert M, Eickhoff A, Ell C, Fahlke J, Feussner H, Fietkau R, Fischbach W, Fleig W, Flentje M, Gabbert HE, Galle PR, Geissler M, Gockel I, Graeven U, Grenacher L, Gross S, Hartmann JT, Heike M, Heinemann V, Herbst B, Herrmann T, Höcht S, Hofheinz RD, Höfler H, Höhler T, Hölscher AH, Horneber M, Hübner J, Izbicki JR, Jakobs R, Jenssen C, Kanzler S, Keller M, Kiesslich R, Klautke G, Körber J, Krause BJ, Kuhn C, Kullmann F, Lang H, Link H, Lordick F, Ludwig K, Lutz M, Mahlberg R, Malfertheiner P, Merkel S, Messmann H, Meyer HJ, Mönig S, Piso P, Pistorius S, Porschen R, Rabenstein T, Reichardt P, Ridwelski K, Röcken C, Roetzer I, Rohr P, Schepp W, Schlag PM, Schmid RM, Schmidberger H, Schmiegel WH, Schmoll HJ, Schuch G, Schuhmacher C, Schütte K, Schwenk W, Selgrad M, Sendler A, Seraphin J, Seufferlein T, Stahl M, Stein H, Stoll C, Stuschke M, Tannapfel A, Tholen R, Thuss-Patience P, Treml K, Vanhoefer U, Vieth M, Vogelsang H, Wagner D, Wedding U, Weimann A, Wilke H, Wittekind C, AWMF, AWMF (2011). German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer". Z Gastroenterol 49(4):461-531
  42. Muders MH (2011). Neuropilin and Neuropilin Associated Molecules as New Molecular Targets in Pancreatic Adenocarcinoma. Anticancer Agents Med Chem 11(5):442-7
  43. Oppel F, Muller N, Schackert G, Hendruschk S, Martin D, Geiger KD , Temme A (2011). SOX2-RNAi attenuates S-phase entry and induces RhoA-dependent switch to protease-independent amoeboid migration in human glioma cells. Mol Cancer 10(1):137
  44. Podlesek D, Geiger K , Hendry DJ, Schackert G, Krex D (2011). Rosette-forming glioneuronal tumor of the fourth ventricle in an elderly patient. J Neurooncol 103(3):727-31
  45. Reeb CA, Gerlach C, Heinssmann M, Prade I , Ceraline J, Roediger J, Roell D, Baniahmad A (2011). A designed cell-permeable aptamer-based corepressor Peptide is highly specific for the androgen receptor and inhibits prostate cancer cell growth in a vector-free mode. Endocrinology 152(6):2174-83
  46. Rowley M, Ohashi A, Mondal G, Mills L, Yang L, Zhang L, Sundsbak R, Shapiro V, Muders M , Smyrk T, Couch FJ (2011). Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice. Gastroenterology . 140(4):1303-1313
  47. Sato S, Kopitz C, Grismayer B, Beaufort N, Reuning U, Schmitt M, Luther T, Kotzsch M , Krüger A, Magdolen V (2011). Overexpression of the urokinase receptor mRNA splice variant uPAR-del4/5 affects tumor-associated processes of breast cancer cells in vitro and in vivo. Breast Cancer Res Treat 127(3):649-57
  48. Scheer F, Kuithan F , Wiggermann P (2011). Fatal outcome of invasive tracheal aspergillosis. Rofo 183(5):480-2
  49. Sergon, M ., Kersting, S., Golgor, E. Aust, D.E., Baretton, G (2011). Autoimmune Pankreatitis vom Typ der lymphoplasmazellulären sklerosierenden Pankreatitis (LPSP). Gastroenterologie up2date 7:7-12
  50. Sockel K, Ordemann R, von Bonin M, Jahn S , Prange-Krex G, Ehninger G, Kroschinsky F (2011). Hip pain in medulloblastoma as first symptom of extraneural relapse. Onkologie 34(4):196-8
  51. Stelling A, Salzer R, Kirsch M, Sobottka SB, Geiger K , Koch E, Schackert G, Steiner G (2011). Intra-operative optical diagnostics with vibrational spectroscopy. Anal Bioanal Chem 400(9):2745-53
  52. Thiele S, Rauner M, Goettsch C, Rachner TD, Benad P, Fuessel S, Erdmann K, Hamann C, Baretton GB , Wirth MP, Jakob F, Hofbauer LC (2011). Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonates. J Cell Biochem 112(6):1593-600
  53. Toma MI , Weber T, Meinhardt M , Zastrow S, Grimm MO, Füssel S, Wirth MP, Baretton GB (2011). Expression of the Forkhead Transcription Factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma. Cancer Invest . 29(2):123-9
  54. Tränkner A, Hass N, Simonis G, Braun-Dullaeus R, Geiger K , Strasser RH (2011). 19-year-old asthma patient with pronounced eosinophilia and acute coronary syndrome. Internist (Berl) 52(12):1479-83
  55. Wiggermann P, Aust D , Stroszczynski C, Kotzerke J, Zöphel K (2011). Follow-up of FDG-PET/CT findings in retroperitoneal fibrosis associated with abdominal aortic aneurysm. Nuklearmedizin 50(3):N21-2
  56. Wolkersdörfer T, Füssel M, Kiesslich T, Neureiter D, Berr F, Aust D , Wolkersdörfer GW (2011). MHC class II genotype- and MHC class I and II phenotype-related parameters in sporadic colorectal cancer. Oncol Rep 26(5):1165-71
  57. Würfel C, Brückner S , Aust DE , Straub S, Hauck F, Laass MW (2011). Intestinal microvascular malformations and congenital asplenia in an adolescent possibly expanding the phenotype of Ivemark syndrome. Eur J Gastroenterol Hepatol 23(12):1258-61